US Patent Issued to Rein Therapeutics on Dec. 16 for "Modified peptide fragments of Cav-1 protein and the use thereof in the treatment of fibrosis" (Texas Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,431, issued on Dec. 16, was assigned to Rein Therapeutics Inc. (Austin, Texas).

"Modified peptide fragments of Cav-1 protein and the use thereof in the treatment of fibrosis" was invented by Dale Christensen (Austin, Texas) and John J. Koleng (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions comprising modified caveolin-1 (Cav-1) peptides. Further provided are methods of using the modified Cav-1 peptides for the treatment of lung infections or acute or chronic lung injury, particularly lung fibrosis."

The patent was filed on Sept. 1, 2023, under Application No. 18/460,215.

*For further information, incl...